A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial

European Journal of Cancer

Volumn 47, Issue 6, 2011, Pages 864-871

  Kitchener, Henry C ^a,e   Gilham, Clare ^b   Sargent, Alexandra ^c   Bailey, Andrew ^c   Albrow, Rebecca ^a   Roberts, Christopher ^a   Desai, Mina ^c   Mather, Jean ^c   Turner, Andrew ^c   Moss, Sue ^d   Peto, Julian ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Cervical; DNA testing; HPV; Screening

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER SCREENING; CANCER STAGING; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GENETIC TESTING; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 79952993791     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.01.008     Document Type: Article

References (16)

1. J. Peto, C. Gilham, O. Fletcher, and F. Matthews The cervical cancer screening epidemic that screening has prevented in the UK Lancet 364 2004 249 256 (Pubitemid 38942814)
2. P. Naucler, W. Ryd, and S. Tornberg Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 16 2007 1589 1597 (Pubitemid 47598401)
3. N.W. Bulkmans, J. Berkhof, and L. Rozendaal Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 9601 2007 1764 1772 (Pubitemid 350137476)
4. G. Ronco, P. Giorgi-Rossi, and F. Carozzi Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial Lancet Oncol 11 3 2010 249 257
5. Kitchener HC, Almonte M, Dowie R et al., ARTISTIC: a randomised trial of HPV testing in primary cervical screening. Health Technol Assess 2009; 13(51).
6. S. Kjaer, E. Hogdall, and K. Frederiksen The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period Cancer Res 66 21 2006 10630 10636 (Pubitemid 44799787)
7. H.C. Kitchener, M. Almonte, and C. Thomson HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial Lancet Oncol 10 7 2009 672 682
8. NHS Cervical Screening Programme, Colposcopy and Programme Management - Guidelines for the NHS Cervical Screening Programme, NHS Cancer Screening Programmes: Sheffield, 2004.
9. J. Paavonen, P. Naud, and J. Salmeron Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Lancet 374 9686 2009 301 314
10. Greenwood M, The natural duration of cancer. Reports on Public Health and Medical Subjects. Her Majesty's Stationery Office: London; 1926. p. 1-26.
11. STATA 11, StataCorp: College Station, TX; 2009.
12. J. Dillner, M. Rebolj, and P. Birembaut Long term predictive values of cytology, human papillomavirus testing in cervical cancer screening: joint European cohort study BMJ 337 2008 a1754
13. A. Szarewski, L. Ambroisine, and L. Cadman Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears Cancer Epidemiol Biomarkers Prev 17 11 2008 3033 3042
14. Franceschi S, Denny L, Irwin KL et al., Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer 2011; [Epub ahead of print].
15. J. Cuzick, A. Castanon, and P. Sasieni Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK Br J Cancer 102 5 2010 933 939
16. M. Kohli, N. Ferko, and A. Martin Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK Br J Cancer 96 1 2007 143 150 (Pubitemid 46094653)